BROWSE·page 13 of 602

Browse EX-10 agreements

7,218 matching material contract exhibits.


FIRST AMENDMENT TO
CREDIT AND SECURITY AGREEMENT

This **FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT **(this “Amendment”), dated as of October 8, 2026, is entered into by and among SARATOGA INVESTMENT FUNDING II LLC, a Delaware limited liability company, as borrower (the “Borrower”), SARATOGA INVESTMENT CORP., a Maryland corporation, as collateral manager (in such capacity, the “Collateral Manager”) and as equityholder (in such capacity, the “Equityholder”), the LENDERS party hereto, VALLEY NATIONAL BANK, as administrative agent for the Secured Parties (in such capacity, the “Administrative Agent”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as collateral administrator (in such capacity, the “Collateral Administrator”) and as collateral agent for the Secured Parties (in such capacity, the “Collateral Agent”).

…

EX-10.1·8-K·CIK 1377936·ACC 0001213900-26-108523·Filed Oct 09, 2026, 16:34 ET

FORM OF NON-REDEMPTION AGREEMENT

Launch Two Acquisition Corp.

NON-REDEMPTION AGREEMENT

This Non-Redemption Agreement (this “Agreement”) is entered as of October 7, 2026 by and among Launch Two Acquisition Corp., a Cayman Islands exempted company (the “Company”), Launch Two Sponsor LLC, a Delaware limited liability company (the “Sponsor”), and the undersigned investor (the “Investor”).

** **

RECITALS

** **

WHEREAS, the Sponsor was initially issued Class B ordinary shares, par value $0.0001 per share, of the Company (the “Class B Ordinary Shares”) in a private placement prior to the Company’s initial public offering (the “IPO”), which Class B Ordinary Shares were converted into Class A Ordinary Shares (as defined below) on September 30, 2026 (such Class A Ordinary Shares issued upon conversion of the Class B Ordinary Shares, the “Founder Shares”);

** **

…

EX-10.1·8-K·CIK 2023676·ACC 0001213900-26-108504·Filed Oct 09, 2026, 16:30 ET

EX-10.1

bioAffinity Technologies, Inc.

SECURITIES PURCHASE AGREEMENT

** **

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into effective as of October 8, 2026, between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

RECITALS

** **

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act (as defined below) as to the Shares and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder as to the Common Warrants and Common Warrant Shares, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, Securities (as defined below) of the Company as more fully described in this Agreement.

AGREEMENT

** **

…

EX-10.1·8-K·CIK 1712762·ACC 0001493152-26-046548·Filed Oct 09, 2026, 16:30 ET

EX-10.2

bioAffinity Technologies, Inc.

** **

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into effective as of October 8, 2026, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agree as follows:

1. Definitions.

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6(d).

…

EX-10.2·8-K·CIK 1712762·ACC 0001493152-26-046548·Filed Oct 09, 2026, 16:30 ET

EXHIBIT 10.1

UNIVERSAL SAFETY PRODUCTS, INC.

**Exhibit 10.1 **

** **

AMENDED AND RESTATED

SECURITIES PURCHASE AGREEMENT

This Amended and Restated Securities Purchase Agreement is entered into and effective as of October 9, 2026 (the “Execution Date”), by and between Universal Safety Products, Inc., a Maryland corporation (the “Company”) and SJC Lending, LLC, a Delaware limited liability company (including its designees, successors and assigns, the “Purchaser”).

RECITALS

WHEREAS, on June 12, 2026 (the “Initial Closing Date”), the Company and the Purchaser entered into the Securities Purchase Agreement (the “Existing Agreement”), pursuant to which, between June 12, 2026 and July 29, 2026, the Company issued to Purchaser, and Purchaser purchased certain convertible promissory notes of the Company in multiple closings under the Existing Agreement in the aggregate principal face amount of $1,590,000 (“Existing Notes”);

…

EX-10.1·8-K·CIK 102109·ACC 0001104659-26-115059·Filed Oct 09, 2026, 16:30 ET

EX-10.1

XMax Inc.

Execution Version

*** ***

SHARE PURCHASE AGREEMENT

This Share Purchase Agreement (this “Agreement”) is made as of October 5, 2026 by and among (a) Professor Yuji Zhao, an individual (the “Seller”), (b) Skysong Innovations, LLC, an Arizona limited liability company (“SI”), (c) Xmax Inc., a Nevada corporation listed on Nasdaq (ticker: XMAX) (“Xmax” or the “Purchaser”), and (d) Hexa Creation Inc., a Delaware corporation (the “Company”, together with the Seller, SI and the Purchaser, collectively, the “Parties” and individually, a “Party”).

RECITALS

WHEREAS, as of the date of this Agreement, (a) the Seller holds 970 shares of common stock of the Company, representing 97% of the total issued and outstanding shares of the Company (the “Seller Shares”), and (b) SI holds 30 shares of common stock of the Company, representing 3% of the total issued and outstanding shares of the Company (the “SI Shares”, and together with the Seller Shares, the “Shares”);

…

EX-10.1·8-K·CIK 1473334·ACC 0001493152-26-046545·Filed Oct 09, 2026, 16:30 ET

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of October 8, 2026 by and between TOP Financial Group Limited (formerly known as Zhong Yang Financial Group Limited), an exempted company incorporated under the laws of the Cayman Islands with limited liability (the “Company”), and Yuli Yan, an individual (the “Executive”). The term “Company” as used herein with respect to all obligations of the Executive hereunder shall be deemed to include the Company and all of its subsidiaries (collectively, the “Group”).

RECITALS

The Company desires to employ the Executive and to assure itself of the services of the Executive during the term of Employment (as defined below).

The Executive desires to be employed by the Company during the term of Employment and upon the terms and conditions of this Agreement.

AGREEMENT

The parties hereto agree as follows:

1. POSITION

…

EX-10.2·8-K·CIK 1848275·ACC 0001213900-26-108497·Filed Oct 09, 2026, 16:30 ET

October 5, 2026

Mr. Dean Huge

1201 SE 2nd Court, Apt. 214

Fort Lauderdale, FL 33301

Dear Mr. Huge,

Appointment Letter for Independent Non-Executive Director

We are pleased to confirm your appointment as an Independent Non-Executive Director of TOP Financial Group Limited (the “Company”), a company incorporated with limited liability under the laws of the Cayman Islands, with effect from October 8, 2026 (the “Effective Date”). This letter (the “Appointment Letter”) sets forth the terms and conditions of your appointment. It is agreed that on acceptance of this offer, this letter will constitute a contract for services and not a contract of employment.

1. The Company and the Group

The Company together with its subsidiaries (collectively, the “Group”) are primarily engaged in providing securities and futures advising, brokerage and asset management services. The Company’s Class A ordinary shares, par value US$0.005 each (the “Class A Ordinary Shares”), are listed on The Nasdaq Stock Market.

2. Appointment

…

EX-10.1·8-K·CIK 1848275·ACC 0001213900-26-108497·Filed Oct 09, 2026, 16:30 ET

EX-10.2

McGraw Hill, Inc.

***Execution Version ***

**AMENDMENT NO. 4 TO THE REVOLVING CREDIT AGREEMENT **

AMENDMENT NO. 4 to the REVOLVING CREDIT AGREEMENT, dated as of October 9, 2026 (this “Amendment”), by and between MAV INTERMEDIATE HOLDING II CORPORATION, a Delaware corporation (“Holdings”), MCGRAW-HILL EDUCATION, INC., a Delaware corporation (the “Lead Borrower”), each of the other Credit Parties party hereto, each of the Lenders and Issuing Banks party hereto, each of the Replacement Lenders (as defined below) (in such capacity, solely with respect to Section 5 hereof) and BANK OF AMERICA, N.A., as administrative agent (in such capacity, the “Administrative Agent”), as collateral agent (in such capacity, the “Collateral Agent”) and as the Swingline Lender;

…

EX-10.2·8-K·CIK 1951070·ACC 0001193125-26-419151·Filed Oct 09, 2026, 16:29 ET

EX-10.1

McGraw Hill, Inc.

***Execution Version ***

**AMENDMENT AND RESTATEMENT AGREEMENT NO. 1 **

This AMENDMENT AND RESTATEMENT AGREEMENT NO. 1 (this “Restatement”) dated as of October 9, 2026 to the CREDIT AGREEMENT, dated as of July 30, 2021 (as amended by Amendment No. 1, dated as of November 1, 2021, Amendment No. 2, dated as of June 26, 2023, Amendment No. 3, dated as of June 27, 2023, Amendment No. 4, dated as of June 27, 2024, as amended by Amendment No. 5, dated as of August 6, 2024, as amended by Amendment No. 6, dated as of February 6, 2025, as amended by Amendment No. 7, dated as of September 8, 2025, and as further amended, restated, amended and restated, supplemented or otherwise modified prior to the Closing Date (as defined below), the “Existing Credit Agreement”; the Existing Credit Agreement, as amended and restated by this restatement, the “Amended and Restated Credit Agreement”), by and among MAV INTERMEDIATE HOLDING II CORPORATION, a Delaware corporation (“Holdings”), MCGRAW-HILL EDUCATION, INC., a Delaware corporation (the “Borrower”), the other Credit Parties party

…

EX-10.1·8-K·CIK 1951070·ACC 0001193125-26-419151·Filed Oct 09, 2026, 16:29 ET

EXHIBIT 10.1

Fluence Energy, Inc.

October 8, 2026

Peter Williams

pbwilliams@sbcglobal.net

Dear Peter,

In connection with your separation from your role as Senior Vice President and Chief Product Officer of Fluence Energy, Inc. (“Fluence” and, together with its affiliated and related entities, the “Company”), we believe it is mutually beneficial to put in writing the terms of such separation.

Your employment with the Company terminated effective September 11, 2026 (the “Termination Date”). In lieu of any severance payments and benefits that you might have in certain circumstances otherwise been eligible to receive under the Fluence Energy, Inc. Executive Severance Plan (the “Executive Severance Plan”), the Company has agreed to provide you with the following payments and benefits, subject to your execution and non-revocation of the release attached hereto as Exhibit A (the “Release”), within 21 days following the date of this letter and the lapse of any revocation period related thereto:

…

EX-10.1·8-K·CIK 1868941·ACC 0001104659-26-115056·Filed Oct 09, 2026, 16:29 ET

EX-10.11

Evernorth Holdings Inc.

**TAX RECEIVABLE AGREEMENT **

**between **

**Evernorth Holdings Inc. **

**and **

**THE PERSONS NAMED HEREIN **

Dated as of October 9, 2026


TABLE OF CONTENTS

| | | | | | | | | -------------------------------------------------------- | - | -------------------------------------------------------------------- | : | :--: | -: | - | | | | | | | | | | | | | | Page | | | | ARTICLE I DEFINITIONS | | | | | 2 | |

…

EX-10.11·8-K·CIK 2092592·ACC 0001193125-26-419146·Filed Oct 09, 2026, 16:25 ET